U.S. flag

An official website of the United States government

NM_001395413.1(POR):c.975C>T (p.Ala325=) AND Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Jan 31, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001088455.12

Allele description [Variation Report for NM_001395413.1(POR):c.975C>T (p.Ala325=)]

NM_001395413.1(POR):c.975C>T (p.Ala325=)

Genes:
LOC126860075:CDK7 strongly-dependent group 2 enhancer GRCh37_chr7:75612087-75613286 [Gene]
POR:cytochrome p450 oxidoreductase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q11.23
Genomic location:
Preferred name:
NM_001395413.1(POR):c.975C>T (p.Ala325=)
HGVS:
  • NC_000007.14:g.75983774C>T
  • NG_008930.1:g.73673C>T
  • NM_001367562.3:c.975C>T
  • NM_001382655.3:c.1029C>T
  • NM_001382657.2:c.975C>T
  • NM_001382658.3:c.975C>T
  • NM_001382659.3:c.975C>T
  • NM_001382662.3:c.975C>T
  • NM_001395413.1:c.975C>TMANE SELECT
  • NP_001354491.2:p.Ala325=
  • NP_001369584.2:p.Ala343=
  • NP_001369586.2:p.Ala325=
  • NP_001369587.2:p.Ala325=
  • NP_001369588.2:p.Ala325=
  • NP_001369591.2:p.Ala325=
  • NP_001382342.1:p.Ala325=
  • NC_000007.13:g.75613092C>T
  • NM_000941.2:c.984C>T
  • p.Ala328Ala
Links:
dbSNP: rs72557941
NCBI 1000 Genomes Browser:
rs72557941
Molecular consequence:
  • NM_001367562.3:c.975C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001382655.3:c.1029C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001382657.2:c.975C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001382658.3:c.975C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001382659.3:c.975C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001382662.3:c.975C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001395413.1:c.975C>T - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency
Synonyms:
DISORDERED STEROIDOGENESIS DUE TO POR DEFICIENCY; Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency
Identifiers:
MONDO: MONDO:0013310; MedGen: C1860042; OMIM: 613571

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001091670Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Likely benign
(Jan 31, 2024) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001322364Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)		Uncertain significance
(Apr 27, 2017) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Genetic variations in NADPH-CYP450 oxidoreductase in a Czech Slavic cohort.

Tomková M, Panda SP, Šeda O, Baxová A, Hůlková M, Siler Masters BS, Martásek P.

Pharmacogenomics. 2015;16(3):205-15. doi: 10.2217/pgs.14.169.

PubMed [citation]
PMID:
25712184
PMCID:
PMC4662547

Details of each submission

From Invitae, SCV001091670.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Illumina Laboratory Services, Illumina, SCV001322364.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024